Foto del docente

Fabrizio De Ponti

Full Professor

Department of Medical and Surgical Sciences

Academic discipline: BIO/14 Pharmacology

Publications

Bakkum M.J.; Richir M.C.; Papaioannidou P.; Likic R.; Sanz E.J.; Christiaens T.; Costa J.N.; Maciulaitis R.; Dima L.; Coleman J.; Tichelaar J.; van Agtmael M.A.; Atanasova I.; Ganeva M.; Gatchev E.; Kostadinova I.I.; Matanovic S.M.; Vitezic D.; Wozniak G.; Kmonickova E.; Urbanek K.; Damkier P.; Huupponen R.K.; Auffret M.; Bejan-Angoulvant T.; Chouchana L.; Cracowski J.-L.; Drici M.D.; Faillie J.L.; Geniaux H.; Molimard M.; Orlikowski D.; Palin K.; Pers Y.-M.; Picard N.; Simon N.; Toussirot E.; Boger R.H.; Cascorbi I.; Mueller S.C.; Regenthal R.; Schwab M.; Schwaninger M.S.; Thuermann P.A.; Wojnowski L.; Kouvelas D.; Riba P.; Kerins D.M.; Williams D.J.; Cosentino M.; De Ponti F.; Filippelli A.; Leone R.; Locatelli V.; Jansone B.; Gulbinovic R.; Mifsud J.; Braszko J.J.; Kocic I.; Breitenfeld L.; Castelo-Branco M.; Conea S.; Magyar I.; Bevc S.; Krzan M.; Bernal M.L.; Capella D.; Carcas A.; De Abajo F.J.; Lopez-Rico M.; Lucena M.I.; Pontes C.; Sanz E.J.; Bottiger Y.; Le Greves M.; de Waard-Siebinga I.; Janssen B.J.A.; Knol W.; Pandit R.; van Rosse F.; Dent G.; Ferro A.; Hitchings A.W.; Kapil V.; Linton K.D.; Loke Y.K.; Okorie M.; Plumb R.D.; Pontefract S.; Ranmuthu S.; Sampson A.P.; Thanacoody H.K.R.; Whitfield J.P.; Wilson K., EurOP2E – the European Open Platform for Prescribing Education, a consensus study among clinical pharmacology and therapeutics teachers, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2021, 77, pp. 1209 - 1218 [Scientific article]Open Access

Gatti M.; Raschi E.; De Ponti F., Fluoroquinolones and Aortic Disease, «JAMA INTERNAL MEDICINE», 2021, 181, pp. 880 - 881 [Scientific article]

Bakkum M.J.; Tichelaar J.; Papaioannidou P.; Likic R.; Sanz Alvarez E.J.; Christiaens T.; Costa J.N.; Maciulaitis R.; Dima L.; Coleman J.; Richir M.C.; van Agtmael M.A.; Atanasova I.; Ganeva M.; Gatchev E.; Kostadinova I.I.; Mimica Matanovic S.; Vitezic D.; Greta W.; Kmonickova E.; Karel U.; Damkier P.; Huupponen R.K.; Auffret M.; Bejan-Angoulvant T.; Laurent C.; Jean-Luc C.; Drici M.D.; Faillie J.L.; Helene G.; Molimard M.; Orlikowski D.; Palin K.; Pers Y.-M.; Picard N.; Simon N.; Toussirot E.; Boger R.H.; Cascorbi I.; Mueller S.C.; Regenthal R.; Schwab M.; Schwaninger M.S.; Thuermann P.A.; Wojnowski L.; Kouvelas D.; Riba P.; Kerins D.M.; Williams D.J.; Cosentino M.; De Ponti F.; Filippelli A.; Leone R.; Locatelli V.; Jansone B.; Gulbinovic R.; Mifsud J.; Braszko Jan J.; Kocic I.; Luiza B.; Castelo-Branco M.; Simona C.; Ioan M.; Bevc S.; Mojca K.; Bernal M.L.; Capella D.; Carcas A.; De Abajo F.J.; Lopez-Rico M.; Lucena M.I.; Pontes C.; Bottiger Y.; Le Greves M.; de Waard-Siebinga I.; Janssen Ben J.A.; Wilma K.; Rahul P.; van Rosse F.; Dent G.; Albert F.; Hitchings A.W.; Kapil V.; Linton K.D.; Loke Y.K.; Michael O.; David P.R.; Pontefract S.; Ranmuthu S.; Sampson A.P.; Thanacoody H.K.R.; Whitfield Jonathan P.; Wilson K., Harmonizing and improving European education in prescribing: An overview of digital educational resources used in clinical pharmacology and therapeutics, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2021, 87, pp. 1001 - 1011 [Scientific article]Open Access

Gatti M.; Raschi E.; De Ponti F., Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis, «EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES», 2021, 40, pp. 1169 - 1176 [Scientific article]Open Access

Gatti M.; Fusaroli M.; Raschi E.; Moretti U.; Poluzzi E.; De Ponti F., Serious adverse events with tedizolid and linezolid: pharmacovigilance insights through the FDA adverse event reporting system, «EXPERT OPINION ON DRUG SAFETY», 2021, 20, pp. 1421 - 1431 [Scientific article]

Gatti M.; Fusaroli M.; Caraceni P.; Poluzzi E.; De Ponti F.; Raschi E., Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID-19, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2021, 87, pp. 1533 - 1540 [Scientific article]

Gatti M.; Raschi E.; De Ponti F., Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2021, 77, pp. 233 - 239 [Scientific article]Open Access

Raschi E.; Fadini G.P.; Diemberger I.; Poluzzi E.; De Ponti F., SGLT2 inhibitors for heart failure with reduced ejection fraction: a real EMPEROR?, «EXPERT OPINION ON PHARMACOTHERAPY», 2021, 22, pp. 647 - 650 [Scientific article]

Raschi E.; La Placa M.; Poluzzi E.; De Ponti F., The value of case reports and spontaneous reporting systems for pharmacovigilance and clinical practice, «BRITISH JOURNAL OF DERMATOLOGY», 2021, 184, pp. 581 - 583 [Scientific article]

Raschi, Emanuel; Fusaroli, Michele; Ardizzoni, Andrea; Poluzzi, Elisabetta; De Ponti, Fabrizio, Thromboembolic Events with Cyclin-Dependent Kinase 4/6 Inhibitors in the FDA Adverse Event Reporting System, «CANCERS», 2021, 13, Article number: 1758 , pp. 1 - 12 [Scientific article]Open Access

Gatti M.; Bianchin M.; Raschi E.; De Ponti F., Assessing the association between fluoroquinolones and emerging adverse drug reactions raised by regulatory agencies: An umbrella review, «EUROPEAN JOURNAL OF INTERNAL MEDICINE», 2020, 75, pp. 60 - 70 [Scientific article]

Raschi E.; Caraceni P.; Poluzzi E.; De Ponti F., Baricitinib, JAK inhibitors and liver injury: a cause for concern in COVID-19?, «EXPERT OPINION ON DRUG SAFETY», 2020, 19, pp. 1367 - 1369 [Comment or similar]

Capelli, Irene; Vitali, Francesca; Zappulo, Fulvia; Martini, Silvia; Donadei, Chiara; Cappuccilli, Maria; Leonardi, Luca; Girardi, Anna; Aiello, Valeria; Galletti, Silvia; Faldella, Giacomo; Poluzzi, Elisabetta; DE Ponti, Fabrizio; Gaetano, LA Manna, Biomarkers of Kidney Injury in Very-low-birth-weight Preterm Infants: Influence of Maternal and Neonatal Factors, «IN VIVO», 2020, 34, pp. 1333 - 1339 [Scientific article]

Raschi E.; Gatti M.; Gelsomino F.; Ardizzoni A.; Poluzzi E.; De Ponti F., Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance, «TARGETED ONCOLOGY», 2020, 15, pp. 449 - 466 [Scientific article]Open Access

Gatti M.; Poluzzi E.; De Ponti F.; Raschi E., Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis, «DRUG SAFETY», 2020, 43, pp. 1277 - 1285 [Scientific article]Open Access